Phase 2 study of bizaxofusp, an IL-4R targeted toxin payload, in nonresectable recurrent GBM: Comparison of overall survival with contemporaneous eligibility-matched and propensity score balanced external control arm.

John H. Sampson; Martin Bexon; Steven Brem; Andrew J. Brenner; Melissa Coello; Sunit Das; Ruthie Davi; Annick Desjardins; Seunggu Jude Han; Santosh Kesari; Sudhir Madduri Karanam; Rosemina Merchant; Joanna J. Phillips; Minh D. To; Michael A. Vogelbaum; Frank Vrionis; Fahar Merchant; Nicholas A. Butowski

doi:10.1200/JCO.2024.42.16_suppl.2079

Phase 2 study of bizaxofusp, an IL-4R targeted toxin payload, in nonresectable recurrent GBM: Comparison of overall survival with contemporaneous eligibility-matched and propensity score balanced external control arm.

John H. Sampson
, Martin Bexon
, Steven Brem
, Andrew J. Brenner
, Melissa Coello
, Sunit Das
, Ruthie Davi
, Annick Desjardins
, Seunggu Jude Han
, Santosh Kesari
, Sudhir Madduri Karanam
, Rosemina Merchant
, Joanna J. Phillips
, Minh D. To
, Michael A. Vogelbaum
, Frank Vrionis
, Fahar Merchant
, Nicholas A. Butowski

Boca Raton Regional Hospital

Research output: Contribution to journal › Review article › peer-review

Original language	English
Pages (from-to)	2079
Number of pages	1
Journal	Journal of Clinical Oncology
Volume	42
DOIs	https://doi.org/10.1200/JCO.2024.42.16_suppl.2079
State	Published - Jun 2024

ASJC Scopus Subject Areas

Oncology
Cancer Research

Access to Document

10.1200/JCO.2024.42.16_suppl.2079

Cite this

Sampson, J. H., Bexon, M., Brem, S., Brenner, A. J., Coello, M., Das, S., Davi, R., Desjardins, A., Han, S. J., Kesari, S., Madduri Karanam, S., Merchant, R., Phillips, J. J., To, M. D., Vogelbaum, M. A., Vrionis, F., Merchant, F., & Butowski, N. A. (2024). Phase 2 study of bizaxofusp, an IL-4R targeted toxin payload, in nonresectable recurrent GBM: Comparison of overall survival with contemporaneous eligibility-matched and propensity score balanced external control arm. Journal of Clinical Oncology, 42, 2079. https://doi.org/10.1200/JCO.2024.42.16_suppl.2079

Phase 2 study of bizaxofusp, an IL-4R targeted toxin payload, in nonresectable recurrent GBM: Comparison of overall survival with contemporaneous eligibility-matched and propensity score balanced external control arm. / Sampson, John H.; Bexon, Martin; Brem, Steven et al.
In: Journal of Clinical Oncology, Vol. 42, 06.2024, p. 2079.

Research output: Contribution to journal › Review article › peer-review

Sampson, JH, Bexon, M, Brem, S, Brenner, AJ, Coello, M, Das, S, Davi, R, Desjardins, A, Han, SJ, Kesari, S, Madduri Karanam, S, Merchant, R, Phillips, JJ, To, MD, Vogelbaum, MA, Vrionis, F, Merchant, F & Butowski, NA 2024, 'Phase 2 study of bizaxofusp, an IL-4R targeted toxin payload, in nonresectable recurrent GBM: Comparison of overall survival with contemporaneous eligibility-matched and propensity score balanced external control arm.', Journal of Clinical Oncology, vol. 42, pp. 2079. https://doi.org/10.1200/JCO.2024.42.16_suppl.2079

@article{3da35f6f5e694d60a480ad73acbf97d0,

title = "Phase 2 study of bizaxofusp, an IL-4R targeted toxin payload, in nonresectable recurrent GBM: Comparison of overall survival with contemporaneous eligibility-matched and propensity score balanced external control arm.",

author = "Sampson, \{John H.\} and Martin Bexon and Steven Brem and Brenner, \{Andrew J.\} and Melissa Coello and Sunit Das and Ruthie Davi and Annick Desjardins and Han, \{Seunggu Jude\} and Santosh Kesari and \{Madduri Karanam\}, Sudhir and Rosemina Merchant and Phillips, \{Joanna J.\} and To, \{Minh D.\} and Vogelbaum, \{Michael A.\} and Frank Vrionis and Fahar Merchant and Butowski, \{Nicholas A.\}",

note = "Publisher Copyright: {\textcopyright} 2024",

year = "2024",

month = jun,

doi = "10.1200/JCO.2024.42.16\_suppl.2079",

language = "English",

volume = "42",

pages = "2079",

journal = "Journal of Clinical Oncology",

issn = "0732-183X",

}

TY - JOUR

T1 - Phase 2 study of bizaxofusp, an IL-4R targeted toxin payload, in nonresectable recurrent GBM

T2 - Comparison of overall survival with contemporaneous eligibility-matched and propensity score balanced external control arm.

AU - Sampson, John H.

AU - Bexon, Martin

AU - Brem, Steven

AU - Brenner, Andrew J.

AU - Coello, Melissa

AU - Das, Sunit

AU - Davi, Ruthie

AU - Desjardins, Annick

AU - Han, Seunggu Jude

AU - Kesari, Santosh

AU - Madduri Karanam, Sudhir

AU - Merchant, Rosemina

AU - Phillips, Joanna J.

AU - To, Minh D.

AU - Vogelbaum, Michael A.

AU - Vrionis, Frank

AU - Merchant, Fahar

AU - Butowski, Nicholas A.

PY - 2024/6

Y1 - 2024/6

UR - https://www.scopus.com/pages/publications/105024705881

UR - https://www.scopus.com/pages/publications/105024705881#tab=citedBy

U2 - 10.1200/JCO.2024.42.16_suppl.2079

DO - 10.1200/JCO.2024.42.16_suppl.2079

M3 - Review article

AN - SCOPUS:105024705881

SN - 0732-183X

VL - 42

SP - 2079

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

ER -

Phase 2 study of bizaxofusp, an IL-4R targeted toxin payload, in nonresectable recurrent GBM: Comparison of overall survival with contemporaneous eligibility-matched and propensity score balanced external control arm.

ASJC Scopus Subject Areas

Access to Document

Other files and links

Cite this